India · Delayed Price · Currency is INR Rossari Biotech Statistics
Total Valuation
Rossari Biotech has a market cap or net worth of INR 29.03 billion. The enterprise value is 31.79 billion.
| Market Cap | 29.03B |
| Enterprise Value | 31.79B |
Important Dates
The last earnings date was Saturday, January 17, 2026.
| Earnings Date | Jan 17, 2026 |
| Ex-Dividend Date | Jun 20, 2025 |
Share Statistics
| Current Share Class | 55.38M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.10% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 53.48% |
| Owned by Institutions (%) | 17.99% |
| Float | 17.64M |
Valuation Ratios
The trailing PE ratio is 21.09 and the forward PE ratio is 18.86.
| PE Ratio | 21.09 |
| Forward PE | 18.86 |
| PS Ratio | 1.27 |
| PB Ratio | 2.32 |
| P/TBV Ratio | 2.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 23.09 |
| EV / Sales | 1.39 |
| EV / EBITDA | 12.05 |
| EV / EBIT | 16.30 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 1.34 |
| Debt / FCF | n/a |
| Interest Coverage | 7.75 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 9.38% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 42.82M |
| Profits Per Employee | 2.57M |
| Employee Count | 535 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Rossari Biotech has paid 482.88 million in taxes.
| Income Tax | 482.88M |
| Effective Tax Rate | 25.96% |
Stock Price Statistics
The stock price has decreased by -22.40% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -22.40% |
| 50-Day Moving Average | 558.87 |
| 200-Day Moving Average | 634.10 |
| Relative Strength Index (RSI) | 41.63 |
| Average Volume (20 Days) | 5,080 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Rossari Biotech had revenue of INR 22.91 billion and earned 1.38 billion in profits. Earnings per share was 24.85.
| Revenue | 22.91B |
| Gross Profit | 7.10B |
| Operating Income | 1.94B |
| Pretax Income | 1.86B |
| Net Income | 1.38B |
| EBITDA | 2.57B |
| EBIT | 1.94B |
| Earnings Per Share (EPS) | 24.85 |
Balance Sheet
The company has 767.93 million in cash and 3.53 billion in debt, with a net cash position of -2.76 billion.
| Cash & Cash Equivalents | 767.93M |
| Total Debt | 3.53B |
| Net Cash | -2.76B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 12.51B |
| Book Value Per Share | 226.03 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 31.01%, with operating and profit margins of 8.45% and 6.01%.
| Gross Margin | 31.01% |
| Operating Margin | 8.45% |
| Pretax Margin | 8.12% |
| Profit Margin | 6.01% |
| EBITDA Margin | 11.20% |
| EBIT Margin | 8.45% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 0.09%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 0.09% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.10% |
| Shareholder Yield | -0.01% |
| Earnings Yield | 4.74% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |